Terizidone (CAS 25683-71-0)
QUICK LINKS
Terizidone is a cycloserine derivative utilized predominantly in microbiological research, particularly in the study of bacterial resistance mechanisms. Its core mechanism involves the inhibition of cell wall synthesis in bacteria, making it useful for probing the intricate processes that bacteria use to resist antibacterial agents. Terizidone specifically targets the alanine racemase and D-alanine:D-alanine ligase enzymes, for peptidoglycan formation, which is essential for bacterial cell wall integrity. By disrupting these enzymatic pathways, terizidone helps researchers understand how alterations in bacterial cell wall synthesis contribute to resistance. This attribute makes terizidone a critical compound in the exploration of novel antimicrobial strategies and in the broader field of bacterial pathogenesis. Its application in laboratory applications facilitates the development of more effective antibacterial agents, as well as enhanced strategies for overcoming bacterial resistance.
Terizidone (CAS 25683-71-0) References
- Short intensified treatment in children with drug-susceptible tuberculous meningitis. | van Toorn, R., et al. 2014. Pediatr Infect Dis J. 33: 248-52. PMID: 24168978
- Prevalence and incidence of symmetrical symptomatic peripheral neuropathy in patients with multidrug-resistant TB. | Conradie, F., et al. 2013. S Afr Med J. 104: 24-6. PMID: 24388081
- Pulmonary disease caused by Mycobacterium marseillense, Italy. | Grottola, A., et al. 2014. Emerg Infect Dis. 20: 1769-70. PMID: 25271594
- Tuberculosis elimination, patients' lives and rational use of new drugs: revisited. | Tiberi, S., et al. 2016. Eur Respir J. 47: 664-7. PMID: 26541536
- The emergence and spread of incurable tuberculosis in South Africa. | McNerney, R. 2016. Int J Mycobacteriol. 5 Suppl 1: S68. PMID: 28043621
- Effectiveness and safety of clofazimine in multidrug-resistant tuberculosis: a nationwide report from Brazil. | Dalcolmo, M., et al. 2017. Eur Respir J. 49: PMID: 28331044
- Making optimal use of available anti-tuberculosis drugs: first steps to investigate terizidone. | Alffenaar, JWC., et al. 2018. Int J Tuberc Lung Dis. 22: 2. PMID: 29297417
- Steady state pharmacokinetics of cycloserine in patients on terizidone for multidrug-resistant tuberculosis. | Court, R., et al. 2018. Int J Tuberc Lung Dis. 22: 30-33. PMID: 29297422
- Analysis of terizidone in plasma using HPLC-UV method and its application in a pharmacokinetic study of patients with drug-resistant tuberculosis. | Mulubwa, M. and Mugabo, P. 2018. Biomed Chromatogr. 32: e4325. PMID: 29947117
- Steady-state population pharmacokinetics of terizidone and its metabolite cycloserine in patients with drug-resistant tuberculosis. | Mulubwa, M. and Mugabo, P. 2019. Br J Clin Pharmacol. 85: 1946-1956. PMID: 31046167
- Amount of Cycloserine Emanating from Terizidone Metabolism and Relationship with Hepatic Function in Patients with Drug-Resistant Tuberculosis. | Mulubwa, M. and Mugabo, P. 2019. Drugs R D. 19: 289-296. PMID: 31396892
- Effect of tablet crushing on drug exposure in the treatment of multidrug-resistant tuberculosis. | Court, R., et al. 2019. Int J Tuberc Lung Dis. 23: 1068-1074. PMID: 31627771
- Population Pharmacokinetics of Cycloserine and Pharmacokinetic/Pharmacodynamic Target Attainment in Multidrug-Resistant Tuberculosis Patients Dosed with Terizidone. | Chirehwa, MT., et al. 2020. Antimicrob Agents Chemother. 64: PMID: 32816738
- Treatment Outcomes and Adverse Drug Effects of Ethambutol, Cycloserine, and Terizidone for the Treatment of Multidrug-Resistant Tuberculosis in South Africa. | van der Walt, ML., et al. 2020. Antimicrob Agents Chemother. 65: PMID: 33046491
- Linezolid-Associated Posterior Reversible Leuco-encephalopathy Syndrome in a Patient with Disseminated Tuberculosis. | Tomar, LR., et al. 2022. Trop Doct. 52: 196-198. PMID: 34866511
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Terizidone, 10 mg | sc-475059A | 10 mg | $129.00 | |||
Terizidone, 25 mg | sc-475059 | 25 mg | $202.00 | |||
Terizidone, 100 mg | sc-475059B | 100 mg | $662.00 | |||
Terizidone, 1 g | sc-475059C | 1 g | $1770.00 |